As of 2025-06-12, the EV/EBITDA ratio of Sire Bioscience Inc (SIRE.CN) is -46.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SIRE.CN's latest enterprise value is 64.76 mil CAD. SIRE.CN's TTM EBITDA according to its financial statements is -1.38 mil CAD. Dividing these 2 quantities gives us the above SIRE.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 8.1x - 12.9x | 10.1x |
Forward P/E multiples | 11.3x - 15.0x | 14.1x |
Fair Price | (0.13) - (0.14) | (0.14) |
Upside | -135.4% - -139.2% | -137.3% |
Date | EV/EBITDA |